Showing 1 - 10 of 14
Persistent link: https://www.econbiz.de/10009427876
Persistent link: https://www.econbiz.de/10011761610
Background: Cost-effectiveness acceptability curves (CEACs) describe the probability that a new treatment or intervention is cost-effective. The net benefit regression framework (NBRF) allows cost-effectiveness analysis to be done in a simple regression framework. The objective of the paper is...
Persistent link: https://www.econbiz.de/10009447217
Persistent link: https://www.econbiz.de/10003731119
Persistent link: https://www.econbiz.de/10009612401
Persistent link: https://www.econbiz.de/10002383437
Persistent link: https://www.econbiz.de/10012040406
Persistent link: https://www.econbiz.de/10011761609
Recently, there has been much interest in using the cost-effectiveness acceptability curve (CEAC) to measure the statistical evidence of cost-effectiveness. The CEAC has two well established but fundamentally different interpretations: one frequentist and one Bayesian. As an alternative, we...
Persistent link: https://www.econbiz.de/10005239340
Economic evaluation is often seen as a branch of health economics divorced from mainstream econometric techniques. Instead, it is perceived as relying on statistical methods for clinical trials. Furthermore, the statistic of interest in cost-effectiveness analysis, the incremental...
Persistent link: https://www.econbiz.de/10005209251